Respiratory syncytial virus immunization patterns in Germany, 2015

Respiratory syncytial virus immunization patterns in Germany, 2015–2020

Published:2024-08-08 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Wick Moritz¹^ORCID,Kliemt Roman²^ORCID,Poshtiban Anahita¹^ORCID,Kossack Nils³^ORCID,Diller Gerhard-Paul⁴⁵^ORCID,Soudani Samira⁶^ORCID,Bangert Mathieu⁶^ORCID,Kramer Rolf⁶^ORCID,Damm Oliver¹^ORCID

Affiliation:

1. Evidence-based Medicine / Health Economics & Outcomes Research, Sanofi-Aventis Deutschland GmbH, Berlin, Germany

2. Health Services Research and Health Economics, WIG2 GmbH, Leipzig, Germany

3. Analytics, WIG2 GmbH, Leipzig, Germany

4. Adult Congenital and Valvular Heart Disease Center, Department of Cardiology and Angiology, University Hospital Muenster, Muenster, Germany

5. Competence Network for Congenital Heart Defects, Deutsches Herzzentrum Berlin, Berlin, Germany

6. Medical Evidence Generation, Sanofi Vaccines, Lyon, France

Funder

AstraZeneca and Sanofi

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2380110

Reference37 articles.

1. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

2. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

3. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

4. SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis

5. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease